VXLLF
VAXIL BIO LTD CDA by Vaxil Bio Ltd. (VXLLF)
$01
About VAXIL BIO LTD CDA by Vaxil Bio Ltd. (VXLLF)
Vaxil Bio Ltd. is an immunotherapy biotech company, which is engaged in the development of immunotherapies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. The firm's pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.
Details
Daily high
$0.02
Daily low
$0.00
Price at open
$0.02
52 Week High
$0.04
52 Week Low
$0.00
Market cap
684,900
Dividend yield
0.00%
Volume
51,900
Avg. volume
59,591
P/E ratio
-7.14
VAXIL BIO LTD CDA by Vaxil Bio Ltd. News
Details
Daily high
$0.02
Daily low
$0.00
Price at open
$0.02
52 Week High
$0.04
52 Week Low
$0.00
Market cap
684,900
Dividend yield
0.00%
Volume
51,900
Avg. volume
59,591
P/E ratio
-7.14